Companies: 10,795·Total market cap: $144.5T
Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

AVXLNASDAQHealthcare● Active
$2.57
+$0.00(+0.19%)
Market Cap$238166418
P/E Ratio
52W High$13.99
52W Low$2.56
Overview

Anavex Life Sciences Corp.(AVXL)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

avxl · 股价预测 · 13 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 13 位华尔街分析师

SellBuy

Buy

13 位分析师

共识

评级分布

Strong Buy
0
Buy
11
Hold
2
Sell
0
Strong Sell
0
合计: 13 · 买入占比: 84.6%

12 个月目标价

High

$11.00

Consensus

$11.00

+326.7% upside

Low

$11.00

Median: $11 · Last Close: $2.58

Anavex Life Sciences Corp.(AVXL)的分析师共识为 Buy,基于过去 3 个月内 13 位华尔街分析师的评级。AVXL 的 12 个月平均目标价为 $11.00,相对当前价 $2.58 代表 +326.7% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

📅
财报窗口期

在 ±3 天财报窗口期内暂停短期预测,以避免不可靠信号。

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-26.2%
2028$2-35.9%
2029$2-40.1%
2030$1-42.0%
2031-43.0%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Elevated Volatility — Earnings Window Active (±3 days)· Technical signals still shown. M3 predictions paused.

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)39.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · AVXL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$2.68SELL
MA 10$2.78SELL
MA 20$2.85SELL
MA 50$3.07SELL
MA 100$3.76SELL
MA 200$5.29SELL
Current $AVXL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.68SELL
EMA 10$2.75SELL
EMA 20$2.86SELL
EMA 50$3.17SELL
EMA 100$3.77SELL
EMA 200$4.91SELL
Current $AVXL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
D. Boral Capital2026-03-31
Maintains
BuyBuy
D. Boral Capital2026-03-26
Maintains
BuyBuy
D. Boral Capital2026-03-23
Maintains
BuyBuy
HC Wainwright & Co.2026-02-10
Maintains
BuyBuy
D. Boral Capital2026-02-09
Maintains
BuyBuy
D. Boral Capital2026-01-06
Maintains
BuyBuy
D. Boral Capital2025-12-19
Maintains
BuyBuy
HC Wainwright & Co.2025-12-19
Maintains
BuyBuy
D. Boral Capital2025-12-15
Maintains
BuyBuy
HC Wainwright & Co.2025-11-28
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Anavex Life Sciences Corp. (AVXL) stock. Of the recent 73 rating actions, 0 were upgrades and 2 were downgrades. 13 analysts currently cover AVXL.

分析师推荐趋势

Buy ratings431
Hold ratings101
Sell ratings00

AVXL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$776M

↑ 122.6% YoY

Revenue Next Year

$1.2B

↑ 55.9% YoY

EPS This Year

$-0.33

EPS Next Year

$-0.55

↑ 66.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AVXL EPS of $-0.33 for the current fiscal year, based on estimates from 1 analysts. The AVXL revenue forecast is $776M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

AVXL 股价预测由两类独立数据源支撑:来自 13 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。AVXL 的共识目标价为 $11.00(+326.7% 上行空间),分析师共识为 Buy。

AVXL 对 2027 年的股价预测均值为 $2。 AVXL 对 2030 年的预测区间为 $1–$2。

Anavex Life Sciences Corp. 在 NASDAQ 上市,代码 AVXL。AVXL 在 2027 年的整体展望偏积极,在覆盖分析师中约 85% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

AVXL 预测 · 8 个问题

根据 13 位华尔街分析师,AVXL 的 12 个月平均目标价为 $11.00,最高 $11.00、最低 $11.00。若有图表,中位目标价可在上方查看。相对当前价 $2.58,隐含约 +326.7% 的上行空间。

AVXL 目标价AVXL 分析师目标价AVXL 12个月目标价目标价 AVXL

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.